The weekly litigation news digest is live. Subscribe now

IP Verse

Genome Fractioning - EP3102722

The patent EP3102722 was granted to Igenomx Genomics on Aug 26, 2020. The application was filed on Feb 3, 2015 under application number EP15746731A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3102722

IGENOMX GENOMICS
Application Number
EP15746731A
Filing Date
Feb 3, 2015
Status
Granted And Under Opposition
Jul 24, 2020
Publication Date
Aug 26, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TAKARA BIO USAMay 26, 2021CARPMAELS & RANSFORDWITHDRAWN

Patent Citations (1) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2013191775

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents